Dr. Reddy's Laboratories500124Pharmaceuticals
Analyst Ajit Mishra recommended accumulating Dr. Reddy's as pharma sector trades at record highs
- Stock move
- 1.8 percent up
- Current price
- 1195 rupees
- Target price
- 1335 rupees
Heard on Live TV News Channel between 10:31:43 - 10:32:58 IST.
- Ajit Mishra of Motilal Oswal said pharma and healthcare sector was holding strong with Nifty Pharma index at record highs.
- He said Dr. Reddy's, along with Sun Pharma and Cipla, was building on gains, up around 1.8%.
- He gave a target of 1335 with the stock at 1195, calling it an accumulation opportunity.
Also from Dr. Reddy's Laboratories
Citi upgraded Dr. Reddy's Laboratories to buy from sell, raising target price to Rs 1450
29 Sep 2026
Dr Reddy's was among the top Nifty gainers after a double upgrade from Citi
29 Sep 2026
Dr Reddy was among the top gainers on the Nifty after a double upgrade from Citi
29 Sep 2026
Source: Live TV News Channel · 29 Sep 2026
The call above is Ajit Mishra's, reported here as they made it. Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.